{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:16:35Z","timestamp":1790705795780,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.msard.2023.104802","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T12:05:23Z","timestamp":1686571523000},"page":"104802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Subclinical optic neuritis in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7318-4865","authenticated-orcid":false,"given":"Linda","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia X.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrel L.","family":"Conger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter V.","family":"Sguigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.msard.2023.104802_bib0027","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.ophtha.2015.06.003","article-title":"Papilledema outcomes from the optical coherence tomography substudy of the idiopathic intracranial hypertension treatment trial","volume":"122","author":"Auinger","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.msard.2023.104802_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2023.104802_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.101988","article-title":"Optimization of spectral domain optical coherence tomography and visual evoked potentials to identify unilateral optic neuritis","volume":"41","author":"Behbehani","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104802_bib0014","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejpn.2020.10.006","article-title":"EU paediatric MOG consortium consensus: part 1\u2013classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","volume":"29","author":"Bruijstens","year":"2020","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.msard.2023.104802_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103525","article-title":"OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MS","volume":"58","author":"Chen","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104802_bib0011","article-title":"The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis","author":"Costello","year":"2013","journal-title":"Int. Sch. Res. Notices"},{"issue":"24","key":"10.1016\/j.msard.2023.104802_bib0018","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1212\/WNL.0000000000002774","article-title":"The APOSTEL recommendations for reporting quantitative optical coherence tomography studies","volume":"86","author":"Cruz-Herranz","year":"2016","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.msard.2023.104802_bib0022","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/bjo.2008.142562","article-title":"Correlation between optical coherence tomography and glaucomatous optic nerve head damage in children","volume":"93","author":"El-Dairi","year":"2009","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.msard.2023.104802_bib0008","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00415-016-8333-7","article-title":"Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration","volume":"264","author":"Havla","year":"2017","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2023.104802_bib0020","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflammat."},{"issue":"3","key":"10.1016\/j.msard.2023.104802_bib0021","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.msard.2023.104802_bib0024","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/adc.82.2.150","article-title":"Sedation of children for magnetic resonance imaging","volume":"82","author":"Lawson","year":"2000","journal-title":"Arch. Dis. Child."},{"issue":"1","key":"10.1016\/j.msard.2023.104802_bib0026","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41433-020-01288-x","article-title":"Optical coherence tomography (OCT) in neuro-ophthalmology","volume":"35","author":"Minakaran","year":"2021","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.msard.2023.104802_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577702","article-title":"Sotirchos ES. Evidence for and against subclinical disease activity and progressive disease in MOG antibody disease and neuromyelitis optica spectrum disorder","volume":"360","author":"Molazadeh","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2023.104802_bib0004","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.msard.2018.11.026","article-title":"Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients","volume":"28","author":"Narayan","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.msard.2023.104802_bib0013","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ana.25462","article-title":"Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: an international study","volume":"85","author":"Nolan-Kenney","year":"2019","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2023.104802_bib0006","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12974-019-1521-5","article-title":"Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study","volume":"16","author":"Oertel","year":"2019","journal-title":"J. Neuroinflammat."},{"issue":"3","key":"10.1016\/j.msard.2023.104802_bib0007","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ana.26440","article-title":"Longitudinal retinal changes in MOGAD","volume":"92","author":"Oertel","year":"2022","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2023.104802_bib0009","article-title":"MOG-IgG-associated disease has a stereotypical clinical course, asymptomatic visual impairment and good treatment response","volume":"4","author":"Pandit","year":"2018","journal-title":"Multiple Scler. J."},{"issue":"4","key":"10.1016\/j.msard.2023.104802_bib0005","doi-asserted-by":"crossref","DOI":"10.1177\/20552173211066446","article-title":"The use of OCT in good visual acuity MOGAD and AQP4-NMOSD patients; with and without optic neuritis","volume":"7","author":"Roca-Fern\u00e1ndez","year":"2021","journal-title":"Multiple Sclerosis J. - Experiment., Translat. Clin."},{"key":"10.1016\/j.msard.2023.104802_bib0001","article-title":"The evolution of myelin oligodendrocyte glycoprotein antibody\u2013associated disease","author":"Sguigna","year":"2023","journal-title":"Pract Neurol"},{"issue":"1","key":"10.1016\/j.msard.2023.104802_bib0019","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/WNO.0000000000001001","article-title":"Utilization of visual acuity retroilluminated charts for the assessment of afferent visual system dysfunction in a pediatric Neuroimmunology population","volume":"41","author":"Sguigna","year":"2021","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.msard.2023.104802_bib0025","first-page":"1","article-title":"Application of the international interocular difference thresholds into practice: localising the patient experience","author":"Sguigna","year":"2022","journal-title":"Neuro-Ophthalmol."},{"issue":"4","key":"10.1016\/j.msard.2023.104802_bib0017","doi-asserted-by":"crossref","first-page":"e34823","DOI":"10.1371\/journal.pone.0034823","article-title":"The OSCAR-IB consensus criteria for retinal OCT quality assessment","volume":"7","author":"Tewarie","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.msard.2023.104802_bib0023","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.msard.2013.10.008","article-title":"Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis","volume":"3","author":"Waldman","year":"2014","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.msard.2023.104802_bib0015","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/WNO.0000000000001070","article-title":"Interocular difference in retinal nerve fiber layer thickness predicts optic neuritis in pediatric-onset multiple sclerosis","volume":"41","author":"Waldman","year":"2021","journal-title":"J. Neuroophthalmol."},{"issue":"6","key":"10.1016\/j.msard.2023.104802_bib0012","doi-asserted-by":"crossref","first-page":"e527","DOI":"10.1212\/WNL.0000000000006873","article-title":"Optical coherence tomography is highly sensitive in detecting prior optic neuritis","volume":"92","author":"Xu","year":"2019","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823003048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823003048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:07:57Z","timestamp":1761901677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823003048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":27,"alternative-id":["S2211034823003048"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.104802","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subclinical optic neuritis in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.104802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104802"}}